STEPHENS INC /AR/ - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
STEPHENS INC /AR/ ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$703,600
-4.5%
6,908
-5.4%
0.01%0.0%
Q2 2023$736,695
+9.0%
7,301
-0.6%
0.01%0.0%
Q1 2023$675,972
+11.4%
7,348
+9.8%
0.01%
+8.3%
Q4 2022$606,873
-2.1%
6,690
-18.0%
0.01%
-7.7%
Q3 2022$620,000
-17.8%
8,159
-8.6%
0.01%
-13.3%
Q2 2022$754,000
-10.0%
8,925
-6.5%
0.02%
+7.1%
Q1 2022$838,000
-21.7%
9,550
-21.9%
0.01%
-12.5%
Q4 2021$1,070,000
-54.4%
12,232
-57.3%
0.02%
-55.6%
Q3 2021$2,345,000
+6.3%
28,675
+18.7%
0.04%
+9.1%
Q2 2021$2,205,000
+11.3%
24,165
+4.2%
0.03%0.0%
Q1 2021$1,982,000
-26.2%
23,191
-18.5%
0.03%
-31.2%
Q4 2020$2,686,000
+9.2%
28,449
+0.6%
0.05%0.0%
Q3 2020$2,459,000
-9.8%
28,277
-9.4%
0.05%
-18.6%
Q2 2020$2,725,000
+11.4%
31,203
+5.1%
0.06%
-9.2%
Q1 2020$2,447,000
+3.1%
29,679
+18.4%
0.06%
+30.0%
Q4 2019$2,374,000
+7.5%
25,075
-1.3%
0.05%
+2.0%
Q3 2019$2,208,000
-6.1%
25,410
-1.3%
0.05%
-7.5%
Q2 2019$2,352,000
+0.1%
25,754
+5.4%
0.05%
-5.4%
Q1 2019$2,350,000
+20.9%
24,445
+7.9%
0.06%
+1.8%
Q4 2018$1,944,000
+0.2%
22,656
+0.6%
0.06%
+14.6%
Q3 2018$1,940,000
+29.2%
22,515
+13.3%
0.05%
+6.7%
Q2 2018$1,501,000
+109.1%
19,872
+122.5%
0.04%
+25.0%
Q4 2013$718,000
-12.1%
8,930
-16.2%
0.04%
-18.2%
Q3 2013$817,000
-2.5%
10,653
-10.1%
0.04%
-6.4%
Q2 2013$838,00011,8450.05%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders